Belangenverstrengeling

Naam Afgevaardige namens Gilead Jansen BMS Abbvie Roche MSD Overig
J.E. Arends NVHB A,R A A,R A,R A VilV (A,R)
J.T. Brouwer NVH, NVMDL A A A A A
M.A.A. Claassen NIV
D.M. Burger NVZA A,L A,L,R A,R A,L R A,L,R,C
J.P.H. Drenth NVH, comm Hepatologie NVMDL A,C,R A A A,R,C A Ipsen (R)
B. van Hoek NVH A A A A Zambon (R), Chiesi (R), Astellas (R), Norgine (A)
A.I.M. Hoepelman NIV A, R A, R A, R ViiV (A, R)
P. Honkoop Comm Hepatologie NVMDL A A A Will Pharma (A)
R.J. de Knegt NVH/NVMDL A,L,R A,L,R A,L,R A,L,R,C L,R Norgine (A,L), Philip (R)
P.A.M. Kracht NIV
K. Sebib Korkmaz NVMDL/NVH
M.J. Sonneveld NVMDL/NVH A A A,L,C
H. van Soest Comm Hepatologie NVMDL
M. van der Valk NVHB A,R,L A,R A A A A,R ViiV (A,R)
S. Willemse NVH, NVMDL A,L,R,C L,R A,L,R A,R,C L,R R